INVESTIGATION OF THE PATHOGENICITY OF SCN5A GENE MUTATIONS IN BRUGADA SYNDROME

Đặng Duy Phương1, Nguyễn Minh Hà2, Đỗ Doãn Lợi1,3, Trần Vân Khánh1, Trần Huy Thịnh1,
1 Hanoi Medical University
2 Pham Ngoc Thach University of Medicine, Ho Chi Minh City
3 Vietnam National Heart Institute

Main Article Content

Abstract

Introduction: Brugada syndrome is an inherited cardiac arrhythmia that causes sudden death. Mutations in the SCN5A gene, which codes for the sodium channel, have been identified as a cause of Brugada syndrome. Because there were several difficulties on conducting in vivo-model experiments and systematic clinical trials, the pathogenesis of novel mutations in the SCN5A gene, which was an important step in the establishment of genotype-phenotype relationship,was in progress in in silico models. Objectives: To determine SCN5A gene mutations in Brugada syndrome patients and to investigate the pathogenicity of these mutations. Subjects and research methods: case series study was carried on Brugada syndrome patients at hospitals in Ho Chi Minh City and Hanoi. The disease was diagnosed according to the European Heart Rhythm Society 2015 criteria. Mutations were identified by Sanger sequencing. Using protein function prediction softwares to investigate the pathogenicity of the mutations. Results: There were 50 patients participating in the study. 14 mutations were detected in the SCN5A gene of 14 patients. These were 10 different types of mutations, of which 4 are novel mutationsthat have not been published in genetic databases. When predicting pathogenicity using bioinformatic softwares, 80% are pathogenic and likely pathogenic. The pathological phenotypes of 12 patients carrying pathogenic or likely pathogenic mutations were described concurrently. Conclusion: The study investigated and determined the pathogenicity for 10 types of SCN5A gene mutations detected in Brugada syndrome patients, using the bioinformatic softwares. Although this isan appropriate approach at this time, it is necessary to have more statistically significant associations between mutations and patients phenotypes to confirm the pathogenicity.

Article Details

References

1. Hosseini, S.M., et al., Reappraisal of reported genes for sudden arrhythmic death: evidence-based evaluation of gene validity for Brugada syndrome. 2018. 138(12): p. 1195-1205.
2. Kapplinger, J.D., et al., An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. 2010. 7(1): p. 33-46.
3. Members, A.T.F., et al., 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). 2015. 17(11): p. 1601-1687.
4. Richards, S., et al., ACMG Laboratory Quality Assurance Committee Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. 2015. 17(5): p. 405-424.
5. http://clinvar.com/, acessed 20/11/2018.
6. Probst, V., et al., Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry. 2010. 121(5): p. 635-643.
7. Kapplinger, J.D., et al., Enhanced classification of Brugada syndrome–associated and long-QT syndrome–associated genetic variants in the SCN5A-encoded Nav1. 5 cardiac sodium channel. 2015. 8(4): p. 582-595.
8. Ackerman, M.J.J.H.r., Genetic purgatory and the cardiac channelopathies: exposing the variants of uncertain/unknown significance issue. 2015. 12(11): p. 2325-2331.
9. Makarawate, P., et al., SCN 5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome. 2017. 6(6): p. e005009.